US Stock MarketDetailed Quotes

RLAY Relay Therapeutics

Watchlist

4.160
-0.100-2.35%

Close Dec 20 16:00 ET

4.200
+0.040+0.96%

Post 20:01 ET

696.31MMarket Cap-1.59P/E (TTM)

Relay Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relay Therapeutics Q3 2024 Earnings Date

Currency：USDNov 6, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	80.00K	0	-80.00K
Miss Est.	-99.68%	-100.00%	-100.00%
EPS	-0.77	-0.63	+0.14
Beat Est.	-42.42%	-16.67%	+18.06%

Analyst Rating

Strong Buy

Dec 12, 2024

Relay Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 50.000K	--
--	2024/Q4	-- / 6.080M	--
Nov 6, 2024	2024/Q3	0.000 / 80.000K	--
Aug 6, 2024	2024/Q2	0.000 / 88.890K	--
May 2, 2024	2024/Q1	10.007M / 109.090K	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 50.000K--

--2024/Q4-- / 6.080M--

Nov 6, 20242024/Q30.000 / 80.000K--

Aug 6, 20242024/Q20.000 / 88.890K--

May 2, 20242024/Q110.007M / 109.090K--

Unlock Free Earnings Estimates

Open Account

Relay Therapeutics Earnings Reports

Relay Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 6 16:20 ET

Relay Therapeutics | 8-K: Relay Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Highlights

Nov 6 16:13 ET

Relay Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6 16:20 ET

Relay Therapeutics | 8-K: Relay Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

Aug 6 16:18 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 12, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data